# Study to Assess the Effect of Pharmacokinetics/Pharmacodynamics (PK/PD) Interaction After co-Administration of Cilostazol With Ginkgo Biloba or Placebo

> **NCT00689858** · PHASE1 · COMPLETED · sponsor: **SK Chemicals Co., Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Cilostazol, Ginkgo biloba and placebo

## Key facts

- **NCT ID:** NCT00689858
- **Lead sponsor:** SK Chemicals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2009-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00689858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00689858, "Study to Assess the Effect of Pharmacokinetics/Pharmacodynamics (PK/PD) Interaction After co-Administration of Cilostazol With Ginkgo Biloba or Placebo". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00689858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*